$MNPR

Monopar Therapeutics Inc

Share on X

$MNPR

Monopar Therapeutics Inc

Past 12mo:2mentions1voices

Share on X

All voices2 mentions since Oct 2025calls only

Loading price chart…

Recent mentions

2 mentions

@adamfeuersteinOct 9, 2025 · 11:29 AM

Here's the story: Monopar $MNPR resurrects a shelved Wilson disease drug. Spotting a possible math problem helped https://t.co/J66XvmgfWQ

Open on X

@adamfeuersteinOct 9, 2025 · 11:29 AM

This week's Biotech Scorecard newsletter: Monopar $MNPR and the resurrection of a shelved drug for Wilson disease. It's a crazy story. AstraZeneca, the drug’s former owner, terminated clinical development in 2023 due to an inadvertent error made in a clinical trial. Monopar acquired the drug last year, and then discovered the mistake, made in a formula used to analyze copper elimination from the body. If approved, possibly in the latter half of 2026, the drug, called ALXN1840, would be the first novel treatment for Wilson disease in 40 years. Monopar plans to submit for U.S. approval early next year.

Open on X

Frequently asked

Who mentions $MNPR most on Surfaced?

@adamfeuerstein (Adam Feuerstein ✡️) mentions $MNPR most — 2 mentions in the past 12 months.

When was $MNPR first mentioned on Surfaced?

The earliest tracked mention of $MNPR in the Surfaced archive was on Oct 9, 2025.

How many voices track $MNPR?

1 FinTwit voice has mentioned $MNPR 2 times in the past 12 months.

What kind of voices mention $MNPR most?

$MNPR is mentioned most by Biotech voices on Surfaced.